"10.1371_journal.pone.0137733","plos one","2015-09-23T00:00:00Z","Ronan Roussel; Christophe Chaignot; Alain Weill; Florence Travert; Boris Hansel; Michel Marre; Philippe Ricordeau; François Alla; Hubert Allemand","INSERM, UMR 872, Centre de Recherche des Cordeliers, 15 rue de lécole de médecine, 75006 Paris, France; Université Paris 7, Faculté de Médecine, 16 rue Huchard, 75018 Paris, France; Hôpital Bichat, AP-HP, Diabetology Endocrinology Nutrition, 46 rue Huchard, 75018 Paris, France; Strategy and Research Department, National Health Insurance, CNAMTS 50, avenue du Professeur André Lemierre 75986 Paris Cedex 20, Paris, France; General division, National Health Insurance, CNAMTS 50, avenue du Professeur André Lemierre 75986 Paris Cedex 20, Paris, France","Conceived and designed the experiments: RR CC PR AW FA. Performed the experiments: RR CC PR AW. Analyzed the data: RR CC PR AW. Contributed reagents/materials/analysis tools: RR CC PR AW FA HA. Wrote the paper: RR CC PR AW FA HA FT BH MM.","Prof. Roussel has received research grants, honoraria, or consulting fees from Sanofi-Aventis, MSD Chibret, Servier, Novo Nordisk, Novartis, BMS, and Janssen-Cilag. Mr. Chaignot, Dr. Weill, Dr. Ricordeau, Prof. Alla, and Prof. Allemand are employees of public institutions. Dr. Travert has received honoraria, or consulting fees from Novonordisk, BMS, MSD Chibret, and Eli Lilly. Dr. Hansel declared no financial conflict related to this work. Prof. Marre is a consultant for Association Diabete Risque Vasculaire and is a speaker or serves on boards for Merck, Sanofi-Aventis, Novo Nordisk, Servier, and Abbott Diagnostics. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","09","Ronan Roussel","RR",9,TRUE,5,4,4,9,TRUE,TRUE,FALSE,0,NA,FALSE
